HOUSTON, TX - (Accesswire - October 8, 2013) - In an effort to keep its shareholders informed on the status of their Company, A5 Laboratories, Inc. (OTC:BB AFLB) is pleased to announce that since Frank Neukomm, Chairman and CEO, and Bob Farr, President and COO, became the management team at A5 in January of 2013, the Company has filed all past due financial reports and is current in its filing status with the SEC.
Management now plans to refocus the Company's business to alternative energy opportunities. As such, the name of A5 Laboratories, Inc. will be changed to reflect the new direction. A new website will be unveiled as part of the new focus.
Management is currently reviewing acquisition candidates and is negotiating financing deals to support the growth prospects of the target companies.
Management is committed to providing periodic updates to shareholders and will announce its achievement of the milestones of the new business plan as they happen.
About A5 Laboratories, Inc.
A5 Laboratories, Inc., (traded as 'AFLB') was previously a contract research organization serving pharmaceutical and biotech companies in North America.
In the future, the Company will focus on alternate energy products and services.
Safe Harbor Statement
The statements in this release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements may not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.
Contact
Frank Neukomm or Bob Farr
[email protected]
713 – 465 – 1001